Literature DB >> 17010586

Immunoregulation by targeting T cells in the treatment of allergy and asthma.

Mark Larché1.   

Abstract

T-cell responses to allergens are crucial in determining the choice between health and disease. Th2 responses drive synthesis of IgE and the recruitment, maturation, survival and effector function of accessory cells such as eosinophils, basophils and mast cells. Allergen-specific strategies for targeting T-cell responses in established allergic diseases have been employed with success for almost a century. Recently, new insight into the mechanism of action of such approaches has revealed modulation of the delicate and complex regulatory mechanisms including suppression of Th2 responses through antagonistic Th1 responses and regulation through IL-10 and TGFbeta production.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010586     DOI: 10.1016/j.coi.2006.09.013

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  22 in total

Review 1.  T-cell responses induced by allergen-specific immunotherapy.

Authors:  E Maggi
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

2.  Suppression of allergic airway inflammation and IgE responses by a class I restricted allergen peptide vaccine.

Authors:  J W Wells; K Choy; C M Lloyd; A Noble
Journal:  Mucosal Immunol       Date:  2008-10-29       Impact factor: 7.313

Review 3.  Allergen immunotherapy for allergic respiratory diseases.

Authors:  Antonio Cappella; Stephen R Durham
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

4.  Caffeic acid phenethyl ester inhibits nuclear factor-kappaB and protein kinase B signalling pathways and induces caspase-3 expression in primary human CD4+ T cells.

Authors:  L-C Wang; K-H Chu; Y-C Liang; Y-L Lin; B-L Chiang
Journal:  Clin Exp Immunol       Date:  2010-01-06       Impact factor: 4.330

5.  Nature of regulatory T cells in the context of allergic disease.

Authors:  Cevdet Ozdemir; Mübeccel Akdis; Cezmi A Akdis
Journal:  Allergy Asthma Clin Immunol       Date:  2008-09-15       Impact factor: 3.406

6.  MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.

Authors:  Andrew J Bordner; Hans D Mittelmann
Journal:  BMC Bioinformatics       Date:  2010-09-24       Impact factor: 3.169

Review 7.  Therapeutic manipulation of immune tolerance in allergic disease.

Authors:  Mübeccel Akdis; Cezmi A Akdis
Journal:  Nat Rev Drug Discov       Date:  2009-08       Impact factor: 84.694

8.  A DNA adjuvant encoding a fusion protein between anti-CD3 single-chain Fv and AIMP1 enhances T helper type 1 cell-mediated immune responses in antigen-sensitized mice.

Authors:  Byeong Cheol Lee; Insug O'Sullivan; Eugene Kim; Sang Gyu Park; Seung Yong Hwang; Daeho Cho; Tae Sung Kim
Journal:  Immunology       Date:  2008-06-10       Impact factor: 7.397

9.  Burn wound γδ T-cells support a Th2 and Th17 immune response.

Authors:  Meenakshi Rani; Qiong Zhang; Martin G Schwacha
Journal:  J Burn Care Res       Date:  2014 Jan-Feb       Impact factor: 1.845

10.  Can we vaccinate against Type 1 diabetes?

Authors:  Mark Peakman
Journal:  F1000 Biol Rep       Date:  2012-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.